Analogs of arginine vasopressin modified in position 3 with (R)-α- hydroxymethylphenylalanine

Journal of Peptide Research

Volumn 53, Issue 5, 1999, Pages 554-559

  Lempicka E ^a   Slaninova, J ^b   Olma, A ^c   Lammek, B ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

(R) hydroxymethylphenylalanine; Arginine vasopressin (AVP); Conformational constraints; V2 agonists

Indexed keywords

ARGIPRESSIN DERIVATIVE; PHENYLALANINE DERIVATIVE;

ARTICLE; DRUG EFFECT; DRUG STRUCTURE; DRUG SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; VASOCONSTRICTION;

ANIMALS; ARGININE VASOPRESSIN; DEAMINO ARGININE VASOPRESSIN; DIURESIS; FEMALE; OXYTOCIN; PHENYLALANINE; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; UTERINE CONTRACTION; VASOCONSTRICTION; VASOPRESSINS;

EID: 0033037506     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-3011.1999.00064.x     Document Type: Article

References (27)

1. Manning, M. & Sawyer, W.H. (1993) Design, synthesis, and some uses of receptor-specific agonists and antagonists of vasopressin and oxytocin. J. Receptor Res. 13, 195-214.
2. Jard, S., Barberis, C., Audigier, S. & Tribollet, E. (1987) Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 72, 173-187.
3. Jard, S. (1988) Mechanisms of action of vasopressin and vasopressin antagonists. Kidney Int. 34, 38-42.
4. Hlavacek, J. (1987) Important structural modifications. I. Noncoded amino acids. In CRC Handbook of Neurohypophyseal Hormone Analogs, Vol. I, Part 2 (K. Jost, M. Lebl, & F, Brtnik, eds). CRC Press, Boca Raton, FL, pp. 109-128.
5. Lammek, B., Czaja, M., Derdowska, I., Rekowski, P., Trzeciak, H.I., Sikora, P., Szkróbka, W., Stojko, R. & Kupryszewski, G. (1997) Influence of L-naphthylalanine in position 3 of AVP and its analogs on their pharmacological properties. J. Peptide Res. 49, 261-268.
6. Metzger, J., Olma, A., Leplawy, M.T. & Jung, G. (1987) Synthesis of a B-lymphocyte activating α-methylserine containing lipopentapeptide. Naturforsch. 42b, 1195-1201.
7. 32] enkephalins elicit a potent long lasting antinociceptive effect. In Peptides, Proceedings of the European Peptide Symposium (C.H. Schneider & A.N. Eberle, eds). ESCOM, Leiden 1993, pp. 657-658.
8. 31 replaced by all β-hydroxyphenylalanine diastereoisomers. Lett. Pept. Sci. 2, 203-205.
9. Olma, A., Misicka, A., Tourwe, D. & Lipkowski, A.W. (1998) Biological consequences of the incorporation of amphiphilic amino acids into opioid peptide sequences. Lett. Pept. Sci. 5, 383-385.
10. Olma, A. (1996) α-Hydroxymethylphenylglycine and α-hydroxymethylphenylalanine: synthesis, resolution, and absolute configuration. Polish J. Chem. 70, 1442-1447.
11. Kamiski, Z.K., Leplawy, M.T. & Zabrocki, J. (1973) α-Hydroxymethylation of α-amino-acids. Synthesis 792-793.
12. Kamiski, Z.K. & Leplawy, M.T. (1974) Preparation of N-acyl-α-alkylserines by selective cleavage of 5-acylamino-5-alkyl-4-oxo-1,3-dioxanes. Synthesis 292-293.
13. Manning, M. (1968) Synthesis by the Merrifield method of a protected nonapeptide amide with the amino acid sequence of oxytocin. J. Am. Chem. Soc. 90, 1348-1349.
14. Lammek, B., Rekowski, P., Kupryszewski, G., Melin, P. & Ragnarsson, U. (1988) Synthesis of arginine-vasopressins, modified in positions 1 and 2, as antagonists of the vasopressor response to the parent hormone. J. Med. Chem. 31, 603-606.
15. Kaiser, E., Colescott, R.L., Bossinger, C.D. & Cook, P. (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 34, 595-598.
16. Christensen, T.C. (1979) A chloroanil color test for monitoring coupling completeness in solid phase peptide synthesis. In Peptides, Structure and Biological Function (E. Gross & J. Meienhofer, eds). Pierce Chemical Company, Rockford, Illinois, p. 385.
17. Holton, P. (1948) A modification of the method of Dale and Laidlaw for standardization of posterior pituitary extract. Br. J. Pharmacol. 3, 328-334.
18. Munsick, R.A. (1960) Effect of magnesium ion on the response of the rat uterus to neurohypophysial hormones and analogs. Endocrinology 66, 451-457.
19. Pliska, V. (1969) Determination of the rate constants of drug elimination from the receptor compartment by an infusion method. Neurohypophyseal hormones and their structure analogs. Eur. J. Pharmacol. 5, 253-262.
20. Dekanski, J. (1952) The quantitative assay of vasopressin. Br. J. Pharmacol. 7, 567-572.
21. Burn, J.H., Finley, D.J. & Goodwin, L.D. (1950) In Biological Standardization, 2nd edn. Oxford University Press, London.
22. Skopkova, J., Hrbas, P. & Barth, T. (1981) Comparison of antidiuretic and natriuretic effects of (8-lysine)vasopressin and (8-D-arginine)deaminovasopressin in conscious rats. Endocrinol. Exptl. 15, 129-138.
23. Slaninova, J. (1987) Fundamental biological evaluation. In CRC Handbook of Neurohypophyseal Hormone Analogs, Vol. I, Part 2 (K. Jost, M. Lebl, & F. Brtnik, eds). CRC Press, Boca Raton, FL, pp. 83-107.
24. Lebl, M., Jost K. & Brtnik, F. (1987) Tables of analogs. In CRC Handbook of Neurohypophyseal Hormone Analogs, Vol. II, Part 2 (K. Jost, M. Lebl, & F. Brtnik, eds). CRC Press, Boca Raton, FL, pp. 127-267.
25. Skopkova, J., Hrbas, P., Slaninova, J. & Barth, T. (1981) Prolonged antidiuretic action of vasopressin analogs in relation to their primary structure. Collection Czech. Chem. Commun. 46, 1850-1855.
26. Kruszyski, M., Lammek, B., Manning, M., Seto, J., Haldar, J. & Sawyer, W.H. (1980) (1-β-mercapto-β,β-cyclopentamethylenepropionic acid), 2-(O-methyl) tyrosine)arginine-vasopressin and [1-β-mercapto-β,β-cyclopentamethylenepropionic acid) )arginine-vasopressin. J. Med. Chem. 23, 364-368.
27. Lammek, B., Czaja, M., Derdowska, I., Łempicka, E., Sikora, P., Szkróbka, W. & Trzeciak, H.I. (1998) Biologically active analogs of arginine vasopressin containing conformationally restricted dipeptide fragments. J. Peptide Res. 51, 149-154.